Ikapharmindo Putramas Tbk. vs Kokoh Exa Nusantara Tbk — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp195 (market cap 330.19B, 200.2K 24h volume), while Kokoh Exa Nusantara Tbk trades at Rp108 (market cap 482.48B, 3.42M 24h volume). The key difference: Kokoh Exa Nusantara Tbk is the larger of the two by market cap, and Kokoh Exa Nusantara Tbk is more actively traded (3.42M versus 200.2K). Which is the better fit depends on your goals.
| IKPM | KOCI | |
|---|---|---|
Market Cap | 330.19B | 482.48B |
Volume | 200.2K | 3.42M |
Lot | 2K | 34.24K |
Turnover | 39.35M | 372.23M |
Average Price | 196.57 | 108.7 |
Value | 39.35M | 372.23M |
Indicative Equilibrium Price | 195 | 109 |
Indicative Equilibrium Volume | 1 | 3.06K |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT Kokoh Exa Nusantara Tbk (the Entity) was established based on Notarial Deed No. 173, dated July 31, 2019 of Dwi Rossulliati, S.H., notary in Mojokerto Regency. The Entity started its commercial operations in 2020. PT Exa Nusa Persada is its ultimate parent entity.
Read more on KOCI →